The Bioterrorism Act Public Health Security and Bioterrorism Preparedness and Response Act of 2002
Biodefense
http://www2.niaid.nih.gov/biodefense/about/default.htm
Improving our nation's defenses against bioterrorism is a key part
of the U.S. government's homeland security effort. The president's 2006
budget requests more than $4 billion for biodefense activities at the
Department of Health and Human Services (HHS) to improve local and state
public health systems, to expand existing biosurveillance efforts, and to
fund research on medical countermeasures against potential bioterror
agents.
Within the HHS biodefense budget, approximately $1.7 billion will fund
medical research and product development at the National Institute of
Allergy and Infectious Diseases (NIAID), part of the National Institutes of
Health. NIAID is committed to accelerating development of medical tools to
detect and counter the effects of a bioterrorist attack, including
- Vaccines to immunize the public
against diseases caused by bioterrorism agents
- Diagnostic tests to help first
responders and other medical personnel rapidly detect exposure and provide
treatment
- Therapies to help patients exposed
to bioterrorism agents regain their health
On June 12, 2002, President Bush signed into law the "Public Health Security and Bioterrorism Preparedness and Response Act of 2002," also known as the Bioterrorism Act
(BTA). Title III of the Act is designed to protect the United States against bio-terrorist threats to its food supply including food from foreign sources. The law will be implemented on December 12, 2003. This law has four major provisions: Registration Prior Notice Administrative Detention Record keeping Registration and Prior Notice will have the greatest impact on the importing community and
CBP. The information posted on this page will provide information on the Act and update you on any issues pertaining to the Act as they pertain to the Bureau of Customs and Border Protection. Food and Drug Administration (FDA) Notices of Proposed Rule Making The FDA issued two Notices of Proposed Rule Making
(NPRM) in the Federal Register on February 3, 2003 outlining proposed regulations to implement the Prior Notice and Registration requirements of the Act. The public comment period on these NPRMs ended on April 4, 2003. Both BTA and the NPRMs are available on the FDA Web site at
www.fda.gov/oc/bioterrorism/bioact.html.
Key provisions include: Registration of Facilities: The Food and Drug Administration (FDA) would require that domestic and foreign facilities that manufacture, process, pack, or hold food for human or animal consumption in the United States register with the FDA by December 12, 2003. FDA is proposing to exempt several types of facilities from the registration requirement including farms, retail facilities, restaurants, and nonprofit food facilities in which food is prepared for or served directly to the consumer. Prior Notice on Importation of Food: The FDA would require that U.S. purchasers or U.S. importers or their agents submit to the FDA prior notice on the importation of food starting no later than December 12, 2003. Examples of commodities listed in the proposed rules that the FDA consider to be food include: fruits; vegetables; fish; dairy products; eggs; raw agricultural commodities for use as food or components of food; animal feed, including pet food; food and feed ingredients and additives, including substances that migrate into food from food packaging and other articles that contact food; dietary supplements and dietary ingredients; infant formula; beverages, including alcoholic beverages and bottled water; live food animals (such as hogs and elk); bakery goods; snack foods; candy; and canned foods. This list is not all-inclusive and will become finalized when the final rule is published. The FDA has sole authority to determine the scope of the covered commodities. The FDA published two NPRMs concerning Administrative Detention and Record Keeping in the Federal Register on May 9, 2003. Submission of Prior Notice Originally, FDA proposed exclusive use of a separate FDA web portal to accept Prior Notice information. However, in response to significant input from the trade community, FDA and the Bureau of Customs and Border Protection
(CBP) announced on May 27 that they will streamline the implementation of the prior notice requirements. The agencies intend to allow food importers to provide the required information on imports to both agencies using an integrated process. FDA and CBP plan to modify the CBP Automated Commercial System, currently used to obtain import information required by Customs to accomplish the bulk of this task. As a result of this collaboration, importers, in most circumstances, will be able to provide the required information to FDA using this existing system, making it easier for them to comply with the new law. Implementation Date The FDA anticipates publishing the Final Rules by October 12, 2003 and the Act will be implemented on December 12, 2003.
|
Project BioShield
Project BioShield - a comprehensive effort to develop
and make available modern, effective drugs and vaccines to protect against
attack by biological and chemical weapons or other dangerous pathogens.
Full
details, click here
Bioterrorism Information & Resources
The bioterrorism section of the website is a collaboration
between IDSA and the Center for
Infectious Disease Research and Policy at the University of Minnesota
with funding from the Centers for Disease
Control and Prevention (CDC) and Pharmacia.
Full
details, click here
Biosecurity and Bioterrorism - Biodefense Strategy, Practice, and
Science
Biodefense and Chemical Detection Research
Resources
Chemical and Biological Information
Chemical and Biological Weapons
Medical Research Insititute of Chemical Defense
The U.S. Army Medical Research Institute of Infectious Diseases
Facts About Sarin
What sarin is?
Where sarin is found and how it is used?
How people can be exposed to sarin?
For more info, click here: http://www.bt.cdc.gov/agent/sarin/basics/facts.asp
|
Most Recent Articles
New Study Finds U.S.
Ill-Prepared to Respond to Bioterrorism; Experts Call for Coordinated Effort
to Develop Drugs and Vaccines to Fight Bioterrorism dated Oct 12, 2004
Research and Markets:
Market Opportunities in Biodefense Research dated Aug 5, 2004
Statement by HHS Secretary Tommy G. Thompsonon on the House Passage of
Project BioShield Authorization Legislation dated July 14 2004
U.S. Has New Concerns About Anthrax Readiness
dated Dec 28, 2003
By JUDITH MILLER NY Times
Web Casts Meeting
"BIODEFENSE: RESEARCH, RESOURCES, AND RESPONSIBILITY"
The War on Terrorism has stimulated interest in and increased support
for research to enhance the ability to detect and counter bioterrorism.
When:
Launching January 2004! Starting @ 1PM Eastern
For more info click here
EPA'S INFO
'SPILLS' SPUR BIOTERROR FEAR
|
The Senate, on a 99-0 vote, approved "Project BioShield" legislation to pay for research, production and stockpiling of vaccines and antidotes for bioterror agents. The House already has approved the legislation, and lawmakers on both sides say they hope to soon have it to President Bush for his signature.
Full story: http://msnbc.msn.com/id/5015485/
|
|
|
|